Skip to content
Business Times – Lifestyle
Author:
Freenome, Inc.
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
July 27, 2026
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
July 20, 2026